Results 11 to 20 of about 49,195 (253)

Thrombin Generation in Acute and Chronic Liver Disease in Children [PDF]

open access: yesDiagnostics
Background: Pediatric liver disease is frequently associated with abnormal conventional coagulation tests; however, prothrombin time expressed as international normalized ratio (PT-INR) incompletely reflect global hemostatic balance.
Giovina Di Felice   +11 more
doaj   +2 more sources

Recurrent venous thromboembolism: association with thrombin generation and d-dimer [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: In patients with a first event of venous thromboembolism (VTE) clinicians must decide when to stop anticoagulation, evaluating the risk of recurrent thrombosis.
Eugenia Biguzzi   +4 more
doaj   +2 more sources

Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes [PDF]

open access: yesBlood Vessels, Thrombosis & Hemostasis
: Plasma levels of tissue factor pathway inhibitor (TFPI) are elevated in many patients with COVID-19 but the role of TFPI in COVID-19 coagulopathy remains elusive.
Alicia S. Eustes   +5 more
doaj   +2 more sources

The effect of combined oral contraceptives on thrombin generation assessed on ST Genesia– a paired clinical study [PDF]

open access: yesThrombosis Journal
Background Treatment with combined oral contraceptives (COC) is associated with an increased risk of venous thromboembolism. Several changes of coagulant and anticoagulant factors induced by ethinyloestradiol during treatment with COC, have been ...
Jesper Strandberg   +4 more
doaj   +2 more sources

Usefulness of Thrombin Generation [PDF]

open access: yesHämostaseologie, 2020
AbstractThrombin generation (TG) is a global coagulation procedure meant to continuously monitor thrombin formation and decay upon exposure of platelet-poor plasma to exogenous triggers such as tissue factor, phospholipids, and calcium chloride. The procedure can also be performed in platelet-rich plasma by omitting exogenous phospholipids.
openaire   +2 more sources

Thrombin generation in the Glasgow Myocardial Infarction Study. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Thrombin is a key protease in coagulation also implicated in complex pathology including atherosclerosis. To address the role of thrombin in relation to myocardial infarction (MI) we explored thrombin generation analysis in plasma from ...
Machiel Smid   +7 more
doaj   +1 more source

Evaluation of the hemostatic potential at coronary artery bypass surgery during long-term aspirin therapy [PDF]

open access: yesТерапевтический архив, 2016
Aim. To estimate thrombin generation test parameters in patients with coronary heart disease during coronary artery bypass surgery under extracorporeal circulation after transfusion of donor platelet concentrates during long-term therapy with ...
O V Gruzdeva   +8 more
doaj   +1 more source

Microparticles and Nucleosomes Are Released From Parenchymal Cells Destroyed After Injury in a Rat Model of Blunt Trauma

open access: yesClinical and Applied Thrombosis/Hemostasis, 2020
We investigated the relationships between circulating procoagulants and trauma severity, including cellular destruction, and the effects of thrombin generation on procoagulants in a rat blunt trauma model. The rats were subjected to tumbling blunt trauma,
Mineji Hayakwa MD, PhD   +8 more
doaj   +1 more source

Defining the boundaries of normal thrombin generation: investigations into hemostasis. [PDF]

open access: yesPLoS ONE, 2012
In terms of its soluble precursors, the coagulation proteome varies quantitatively among apparently healthy individuals. The significance of this variability remains obscure, in part because it is the backdrop against which the hemostatic consequences of
Christopher M Danforth   +4 more
doaj   +1 more source

In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in emergency situations. Controversy exists whether 4F‐PCC is as effective as andexanet
Herm Jan M. Brinkman   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy